Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Novel luciferase‐based glucagon‐like peptide 1 reporter assay reveals naturally occurring secretagogues

View through CrossRef
Background and PurposeGlucagon‐like peptide 1 (GLP‐1) is a hormone derived from preproglucagon. It is secreted by enteroendocrine cells in response to feeding and, in turn, acts as a critical regulator of insulin release. Modulating GLP‐1 secretion holds promise as a strategy for controlling blood glucose levels.Experimental ApproachTo dissect GLP‐1 regulation and discover specific secretagogues, we engineered a reporter cell line introducing a luciferase within the proglucagon sequence in GLUTag cells. The assay was validated using western blotting and ELISA. A focused natural compounds library was screened. We measured luminescence, glucose uptake and ATP to investigate the mechanism by which newly found secretagogues potentiate GLP‐1 secretion.Key ResultsThe newly created reporter cell line is ideal for the rapid, sensitive and quantitative assessment of GLP‐1 secretion. The small molecule screen identified non‐toxic GLP‐1 modulators. Quercetin is the most potent newly found GLP‐1 secretagogue, while other flavonoids also potentiate GLP‐1 secretion. Quercetin requires glucose and extracellular calcium to act as GLP‐1 secretagogue. Our results support a mechanism whereby flavonoids cause GLUTag cells to utilize glucose more efficiently, leading to elevated ATP levels, followed by KATP channel blockade and GLP‐1 exocytosis.Conclusion and ImplicationsOur methodology enabled finding of new GLP‐1 secretagogues. Quercetin is a potent, naturally occurring GLP‐1 secretagogue. Mechanistic studies of newly found secretagogues are possible in newly created reporter cell line. Further validation in more physiological systems, such as primary L‐cells or whole organisms, is needed. GLP‐1 secretagogues might serve as leads for developing alternative glucose‐lowering therapies.
Title: Novel luciferase‐based glucagon‐like peptide 1 reporter assay reveals naturally occurring secretagogues
Description:
Background and PurposeGlucagon‐like peptide 1 (GLP‐1) is a hormone derived from preproglucagon.
It is secreted by enteroendocrine cells in response to feeding and, in turn, acts as a critical regulator of insulin release.
Modulating GLP‐1 secretion holds promise as a strategy for controlling blood glucose levels.
Experimental ApproachTo dissect GLP‐1 regulation and discover specific secretagogues, we engineered a reporter cell line introducing a luciferase within the proglucagon sequence in GLUTag cells.
The assay was validated using western blotting and ELISA.
A focused natural compounds library was screened.
We measured luminescence, glucose uptake and ATP to investigate the mechanism by which newly found secretagogues potentiate GLP‐1 secretion.
Key ResultsThe newly created reporter cell line is ideal for the rapid, sensitive and quantitative assessment of GLP‐1 secretion.
The small molecule screen identified non‐toxic GLP‐1 modulators.
Quercetin is the most potent newly found GLP‐1 secretagogue, while other flavonoids also potentiate GLP‐1 secretion.
Quercetin requires glucose and extracellular calcium to act as GLP‐1 secretagogue.
Our results support a mechanism whereby flavonoids cause GLUTag cells to utilize glucose more efficiently, leading to elevated ATP levels, followed by KATP channel blockade and GLP‐1 exocytosis.
Conclusion and ImplicationsOur methodology enabled finding of new GLP‐1 secretagogues.
Quercetin is a potent, naturally occurring GLP‐1 secretagogue.
Mechanistic studies of newly found secretagogues are possible in newly created reporter cell line.
Further validation in more physiological systems, such as primary L‐cells or whole organisms, is needed.
GLP‐1 secretagogues might serve as leads for developing alternative glucose‐lowering therapies.

Related Results

Postprandial Glucagon Action in the Human Brain
Postprandial Glucagon Action in the Human Brain
ABSTRACT Aims Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood...
Glucagon and Its Receptors in the Mammalian Heart
Glucagon and Its Receptors in the Mammalian Heart
Glucagon exerts effects on the mammalian heart. These effects include alterations in the force of contraction, beating rate, and changes in the cardiac conduction system axis. The ...
The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
SummaryGlucagon‐like peptide 1 plays a role in glucose regulation. Sleep disturbances (obstructive sleep apnea, insufficient or poor sleep quality) have been shown to adversely aff...
34-OR: Postprandial Glucagon Action in the Human Brain
34-OR: Postprandial Glucagon Action in the Human Brain
While elevated fasting glucagon is linked to hyperglycemia, the impact of postprandial changes in glucagon is less clear. Recent findings suggest potential metabolic benefits of ri...
62-OR: Evidence of Gut-Derived Glucagon in Man
62-OR: Evidence of Gut-Derived Glucagon in Man
We have previously shown that totally pancreatectomized patients (PX) and patients with type 2 diabetes (T2D) exhibit hypersecretion of glucagon in response to oral glucose stimula...
Role of glucagon in protein catabolism
Role of glucagon in protein catabolism
Purpose of review Glucagon is known as a key hormone in the control of glucose and amino acid metabolism. Critical illness is hallmarked by a profound alteration in glu...
La strana coppia
La strana coppia
Glucagon assays employing specific radioimmunoassay (RIA) techniques are now widely used to characterize pathologic conditions where the effect of the excess or deficiency of gluca...

Back to Top